http://archive.fast-edgar.com/20240606/AS2ZU62DZZ2RDZZK22JO2ZYJQ4FSZZ22Z862
Filed on: June 6, 2024
June 6, 2024
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Re: Notice of Disclosure Filed in the Semi-Annual Report on Form N-CSR Under Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Exchange Act
To Whom it May Concern:
Pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Securities Exchange... (continue reading...)
Registration Statement No. 333-275898
Filed Pursuant to Rule 424(b)(2)
Pricing Supplement
Pricing Supplement Dated June 4, 2024 to the Prospectus dated December 20, 2023, the Prospectus Supplement dated December 20, 2023 and the Product Supplement No. 1A dated May 16, 2024
$1,821,000 Issuer Callable Contingent Coupon Barrier Notes Linked to the Common Stock of... (continue reading...)
united states securities and exchange commission washington, d.c. 20549 form n-csr certified shareholder report of registered management investment companies
Investment Company Act file number 811-21237
Unified Series Trust
(Exact name of registrant as specified in charter)
225 Pictoria Drive, Suite 450
Cincinnati, OH 45246
(Address of principal executive offices)
(Zip code)
Zachary P. Richmond
Ultimus Fund Solutions, LLC
225... (continue reading...)
The information in this preliminary pricing supplement is not complete and may be changed. A registration statement relating to these notes has been filed with the Securities and Exchange Commission. This preliminary pricing supplement and the accompanying product supplement, prospectus supplement and prospectus are not an offer to sell these notes, nor are they soliciting an offer to buy these notes, in any state where the offer or sale is not permitted.
SUBJECT... (continue reading...)
More SEC Filings
View Older Stories-
Form D EXCELSIOR INVESTMENT
-
Form 4 RED RIVER BANCSHARES For: Jun 04 Filed by: Crowell Michael D.
-
Form 11-K GOODYEAR TIRE & RUBBER For: Dec 31
-
Form 144 Olema Pharmaceuticals, Filed by: Logos Opportunities Fund II LP
-
Form D Pomeroy Land Holding
-
Form 424B2 CITIGROUP INC
-
Form 144 Ginkgo Bioworks Holdings Filed by: Che Austin
-
Form 144 Olema Pharmaceuticals, Filed by: Logos Opportunities Fund I LP
-
Form D SiTration, Inc.
-
Form 4 MODINE MANUFACTURING CO For: Jun 04 Filed by: Lucareli Michael B
-
Form 425 Aimfinity Investment Filed by: Aimfinity Investment Corp. I
-
Form 8-K Aimfinity Investment For: Jun 05
-
Form 4 MODINE MANUFACTURING CO For: Jun 04 Filed by: Brinker Neil David
-
Form 24F-2NT Columbia ETF Trust II For: Mar 31
-
Form 25-NSE Listed Funds Trust Filed by: NYSE ARCA, INC.
-
Form 4 Texas Pacific Land Corp For: Jun 05 Filed by: HORIZON KINETICS ASSET MANAGEMENT LLC
-
Form 4 MODINE MANUFACTURING CO For: Jun 04 Filed by: Agen Brian Jon
-
Form 6-K FORTUNA SILVER MINES For: Jun 06
-
Form N-MFP2 DAVIS SERIES INC For: May 31
-
Form 424B2 BofA Finance LLC
-
Form SC 13G/A SILICOM LTD. Filed by: WELLINGTON TRUST Co N A
-
Form 144 AMAZON COM INC Filed by: Selipsky Adam
-
Form POS AM SharpLink Gaming, Inc.
-
Form SC 13G/A Zai Lab Ltd Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G CompoSecure, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A Genpact LTD Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A Sage Therapeutics, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A LUXFER HOLDINGS PLC Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A FLEX LTD. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A SILICOM LTD. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A Acadia Healthcare Compan Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form 4 LAKE AREA CORN PROCESSOR For: Jun 01 Filed by: Hansen Randall Lloyd
-
Form 4 Princeton Bancorp, Inc. For: Jun 04 Filed by: TUCHMAN MARTIN
-
Form D/A TRUCK CAPITAL OFFSHORE,
-
Form 424B2 CITIGROUP INC
-
Form 424B2 BANK OF NOVA SCOTIA
-
Form 11-K/A FIRST MERCHANTS CORP For: Dec 31
-
Form N-CSRS SEI INSTITUTIONAL INTERN For: Mar 31
-
Form D Cinsano Pharma, Inc.
-
Form 424B2 CITIGROUP INC
-
Form DEF 14A Lucid Diagnostics Inc. For: Jun 06
-
Form D/A Cheetah Korea Value Fund
-
Form 424B2 MORGAN STANLEY
-
Form CERT Fly-E Group, Inc.
-
Form 424B2 MORGAN STANLEY
-
Form D CE-0530 Fund I, a series
-
Form 40-17G THRIVENT MUTUAL FUNDS
-
Form 4 MetroCity Bankshares, For: Jun 05 Filed by: Shim Sam Sang-Koo
-
Form 424B2 UBS AG
-
Form SEC STAFF LETTER Ferrovial SE